AstraZeneca publish series of cyclin-dependent kinase inhibitors

AstraZeneca have published a series of Imidazole cyclin-dependent kinase (CDK) inhibitors

Roche to present at ESMO

Roche have announced that 100+ abstracts on Roche medicines will be presented at the upcoming European Society for Medical Oncology (ESMO) meeting.

Key presentations include:
* Data from AVAiL, confirming the use of Avastin as first line treatment in NSCLC
* Phase III data on continuation of Herceptin treatment
* Phase II data data on the use of [...]

GSK and Cellzome sign strategic alliance to discover kinase-targeted therapeutics

Cellzome and GlaxoSmithKline have entered in to an alliance to discover, develop and market novel kinase  therapeutics to treat inflammatory diseases.